title: Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.
abstract: Ferrets are a valuable model for influenza virus pathogenesis, virus transmission, and antiviral therapy studies. However, the contributions of the volume of inoculum administered and the ferret's respiratory tract anatomy to disease outcome have not been explored. We noted variations in clinical disease outcomes and the volume of inoculum administered and investigated these differences by administering two influenza viruses (A/California/07/2009 [H1N1 pandemic] and A/Minnesota/11/2010 [H3N2 variant]) to ferrets intranasally at a dose of 10(6) 50% tissue culture infective doses in a range of inoculum volumes (0.2, 0.5, or 1.0 ml) and followed viral replication, clinical disease, and pathology over 6 days. Clinical illness and respiratory tract pathology were the most severe and most consistent when the viruses were administered in a volume of 1.0 ml. Using a modified micro-computed tomography imaging method and examining gross specimens, we found that the right main-stem bronchus was consistently larger in diameter than the left main-stem bronchus, though the latter was longer and straighter. These anatomic features likely influence the distribution of the inoculum in the lower respiratory tract. A 1.0-ml volume of inoculum is optimal for delivery of virus to the lower respiratory tract of ferrets, particularly when evaluation of clinical disease is desired. Furthermore, we highlight important anatomical features of the ferret lung that influence the kinetics of viral replication, clinical disease severity, and lung pathology.
  
  
  OBJECTIVE
  Ferrets are a valuable model for influenza virus pathogenesis, virus transmission, and antiviral therapy studies. Clinical disease in ferrets is an important parameter in evaluating the virulence of novel influenza viruses, and findings are extrapolated to virulence in humans. Therefore, it is highly desirable that the data from different laboratories be accurate and reproducible. We have found that, even when the same virus was administered at similar doses, different investigators reported a range of clinical disease outcomes, from asymptomatic infection to severe weight loss, ocular and nasal discharge, sneezing, and lethargy. We found that a wide range of inoculum volumes was used to experimentally infect ferrets, and we sought to determine whether the variations in disease outcome were the result of the volume of inoculum administered. These data highlight some less explored features of the model, methods of experimental infection, and clinical disease outcomes in a research setting.
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Ian N
authors.initials: IN
authors.lastname: Moore
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Elaine W
authors.initials: EW
authors.lastname: Lamirande
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Myeisha
authors.initials: M
authors.lastname: Paskel
authors.affiliation: Mouse Imaging Facility, NINDS, NIH, Bethesda, Maryland, USA.
authors.forename: Danielle
authors.initials: D
authors.lastname: Donahue
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Heather
authors.initials: H
authors.lastname: Kenney
authors.affiliation: Biostatistics Research Branch, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Jing
authors.initials: J
authors.lastname: Qin
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA ksubbarao@niaid.nih.gov.
authors.forename: Kanta
authors.initials: K
authors.lastname: Subbarao
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D005289:Ferrets; D006651:Histocytochemistry; D053118:Influenza A Virus, H1N1 Subtype / Q000254:growth & development*; D053122:Influenza A Virus, H3N2 Subtype / Q000254:growth & development*; D008297:Male; D009976:Orthomyxoviridae Infections / Q000473:pathology* / Q000821:virology*; D012137:Respiratory System / Q000473:pathology* / Q000821:virology*; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed; D019562:Viral Load